Terumo Corporation (TYO:4543)
2,469.50
+38.50 (1.58%)
Nov 26, 2025, 2:35 PM JST
Terumo Revenue
Terumo had revenue of 274.97B JPY in the quarter ending September 30, 2025, with 9.77% growth. This brings the company's revenue in the last twelve months to 1.06T, up 7.68% year-over-year. In the fiscal year ending March 31, 2025, Terumo had annual revenue of 1.04T with 12.40% growth.
Revenue (ttm)
1.06T
Revenue Growth
+7.68%
P/S Ratio
3.38
Revenue / Employee
34.73M
Employees
30,591
Market Cap
3.59T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.04T | 114.31B | 12.40% |
| Mar 31, 2024 | 921.86B | 101.65B | 12.39% |
| Mar 31, 2023 | 820.21B | 116.91B | 16.62% |
| Mar 31, 2022 | 703.30B | 89.46B | 14.57% |
| Mar 31, 2021 | 613.84B | -15.06B | -2.39% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.42T |
| Otsuka Holdings | 2.42T |
| Astellas Pharma | 2.01T |
| Daiichi Sankyo Company | 1.98T |
| Chugai Pharmaceutical | 1.21T |
| Olympus | 977.65B |
| HOYA Corporation | 892.50B |
| Eisai | 804.39B |
Terumo News
- 13 days ago - Q2 2026 Terumo Corp Earnings Presentation Transcript - GuruFocus
- 13 days ago - Terumo Corporation (TRUMY) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Terumo reports 1H results - Seeking Alpha
- 26 days ago - OrganOx Completes Acquisition by Terumo Corporation to Advance the Future of Organ Transplantation - GlobeNewsWire
- 4 weeks ago - Orchestra BioMed, Terumo Sign $30 Million Strategic Agreements For Virtue SAB - Nasdaq
- 3 months ago - Terumo Acquiring Its Way Into The Intriguing Organ Donation Market - Seeking Alpha
- 3 months ago - Terumo Corp (TRUMF) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... - GuruFocus
- 3 months ago - Q1 2026 Terumo Corp Earnings Call Transcript - GuruFocus